Rapid visual detection of Helicobacter pylori and vacA subtypes by Dual-Target RAA-LFD assay
Sijie Yin,Yanghe Liu,Xinyi Yang,Nasifu Lubanga,Ping Tai,Mengqiu Xiong,Boyue Fan,Xincheng Yang,Zhenlin Nie,Qingsong Zhang,Bangshun He
DOI: https://doi.org/10.1016/j.cca.2024.119927
IF: 6.314
2024-08-18
Clinica Chimica Acta
Abstract:Background Helicobacter pylori ( H. pylori ) infects over 50% of the global population and is a significant risk factor for gastric cancer. The pathogenicity of H. pylori is primarily attributed to virulence factors such as vacA . Timely and accurate identification, along with genotyping of H. pylori virulence genes, are essential for effective clinical management and controlling its prevalence. Methods In this study, we developed a dual-target RAA-LFD assay for the rapid, visual detection of H. pylori genes ( 16 s rRNA , ureA , vacA m1 / m2 ), using recombinase aided amplification (RAA) combined with lateral flow dipstick (LFD) methods. Both 16 s rRNA and ureA were selected as identification genes to ensure reliable detection accuracy. Results A RAA-LFD assay was developed to achieve dual-target amplification at a stable 37 °C within 20 min, followed by visualization using the lateral flow dipstick (LFD). The whole process, from amplification to results, took less than 30 min. The 95 % limit of detection (LOD) for 16 s rRNA and ureA , vacA m1 , vacA m2 were determined as 3.8 × 10 -2 ng/μL, 5.8 × 10 -2 ng/μL and 1.4 × 10 -2 ng/μL, respectively. No cross-reaction was observed in the detection of common pathogens including Escherichia coli , Klebsiella pneumoniae , Enterococcus faecalis , Staphylococcus aureus , Pseudomonas aeruginosa , and Bacillus subtilis , showing the assay's high specificity. In the evaluation of the clinical performance of the RAA-LFD assay. A total of 44 gastric juice samples were analyzed, immunofluorescence staining (IFS) and quantitative polymerase chain reaction (qPCR) were used as reference methods. The RAA-LFD results for the 16 s rRNA and ureA genes showed complete agreement with qPCR findings, accurately identifying H. pylori infection as confirmed by IFS in 10 out of the 44 patients. Furthermore, the assay successfully genotyped vacA m1 / m2 among the positive samples, showing complete agreement with qPCR results and achieving a kappa (κ) value of 1.00. Conclusion The dual-target RAA-LFD assay developed in this study provides a rapid and reliable method for detecting and genotyping H. pylori within 30 min, minimizing dependency on sophisticated laboratory equipment and specialized personnel. Clinical validation confirms its efficacy as a promising tool for effectively control of its prevalence and aiding in the precise treatment of H. pylori -associated diseases.
medical laboratory technology